Literature DB >> 21815188

Erythrocyte pyruvate kinase deficiency in an old-order Amish cohort: longitudinal risk and disease management.

Nicholas L Rider1, Kevin A Strauss, Krysta Brown, Armin Finkenstedt, Erik G Puffenberger, Christine L Hendrickson, Donna L Robinson, Nikolas Muenke, Chris Tselepis, Lauren Saunders, Heinz Zoller, D Holmes Morton.   

Abstract

Pyruvate kinase deficiency is a chronic illness with age specific consequences. Newborns suffer life-threatening hemolytic crisis and hyperbilirubinemia. Adults are at risk for infections because of asplenia, pregnancy-related morbidity, and may suffer organ damage because of systemic iron overload. We describe 27 Old Order Amish patients (ages 8 months-52 years) homozygous for c.1436G>A mutations in PKLR. Each subject had a predictable neonatal course requiring packed red blood cell transfusions (30 ± 5 mL/kg) to control hemolytic disease and intensive phototherapy to prevent kernicterus. Hemochromatosis affected 29% (n = 4) of adult patients, who had inappropriately normal serum hepcidin (34.5 ± 12.7 ng/mL) and GDF-15 (595 ± 335pg/mL) relative to hyperferritinemia (769 ± 595 mg/dL). A high prevalence of HFE gene mutations exists in this population and may contribute to iron-related morbidity. Based on our observations, we present a strategy for long-term management of pyruvate kinase deficiency. 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21815188     DOI: 10.1002/ajh.22118

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  10 in total

1.  Genotype-phenotype correlation and molecular heterogeneity in pyruvate kinase deficiency.

Authors:  Paola Bianchi; Elisa Fermo; Kimberly Lezon-Geyda; Eduard J van Beers; Holmes D Morton; Wilma Barcellini; Bertil Glader; Satheesh Chonat; Yaddanapudi Ravindranath; Peter E Newburger; Nina Kollmar; Jenny M Despotovic; Madeleine Verhovsek; Mukta Sharma; Janet L Kwiatkowski; Kevin H M Kuo; Marcin W Wlodarski; Hassan M Yaish; Susanne Holzhauer; Heng Wang; Joachim Kunz; Kathryn Addonizio; Hasan Al-Sayegh; Wendy B London; Oliver Andres; Richard van Wijk; Patrick G Gallagher; Rachael F F Grace
Journal:  Am J Hematol       Date:  2020-03-06       Impact factor: 10.047

2.  From rumors to genetic isolates.

Authors:  Eduardo E Castilla; Lavinia Schuler-Faccini
Journal:  Genet Mol Biol       Date:  2014-03       Impact factor: 1.771

Review 3.  Erythrocyte pyruvate kinase deficiency: 2015 status report.

Authors:  Rachael F Grace; Alberto Zanella; Ellis J Neufeld; D Holmes Morton; Stefan Eber; Hassan Yaish; Bertil Glader
Journal:  Am J Hematol       Date:  2015-08-14       Impact factor: 10.047

Review 4.  Diagnostic approaches for inherited hemolytic anemia in the genetic era.

Authors:  Yonggoo Kim; Joonhong Park; Myungshin Kim
Journal:  Blood Res       Date:  2017-06-22

5.  Comorbidities and complications in adults with pyruvate kinase deficiency.

Authors:  Audra N Boscoe; Yan Yan; Elizabeth Hedgeman; Eduard J van Beers; Hanny Al-Samkari; Wilma Barcellini; Stefan W Eber; Bertil Glader; Hassan M Yaish; Satheesh Chonat; Mukta Sharma; Kevin H M Kuo; Ellis J Neufeld; Heng Wang; Madeleine Verhovsek; Sujit Sheth; Rachael F Grace
Journal:  Eur J Haematol       Date:  2021-01-24       Impact factor: 2.997

6.  Novel PKLR missense mutation (A300P) causing pyruvate kinase deficiency in an Omani Kindred-PK deficiency masquerading as congenital dyserythropoietic anemia.

Authors:  Naglaa Fawaz; Ismail Beshlawi; Alauldeen Alqasim; Mathew Zachariah; Roberta Russo; Immacolata Andolfo; Antonella Gambale; Anil Pathare; Achille Iolascon
Journal:  Clin Case Rep       Date:  2022-02-07

Review 7.  Pyruvate Kinase Deficiency: Current Challenges and Future Prospects.

Authors:  Bruno Fattizzo; Francesca Cavallaro; Anna Paola Maria Luisa Marcello; Cristina Vercellati; Wilma Barcellini
Journal:  J Blood Med       Date:  2022-09-01

Review 8.  Regulation of pyruvate metabolism and human disease.

Authors:  Lawrence R Gray; Sean C Tompkins; Eric B Taylor
Journal:  Cell Mol Life Sci       Date:  2013-12-21       Impact factor: 9.261

Review 9.  Molecular heterogeneity of pyruvate kinase deficiency.

Authors:  Paola Bianchi; Elisa Fermo
Journal:  Haematologica       Date:  2020-09-01       Impact factor: 9.941

10.  Health-related quality of life and fatigue in children and adults with pyruvate kinase deficiency.

Authors:  Hanny Al-Samkari; Eduard J van Beers; D Holmes Morton; Stefan W Eber; Satheesh Chonat; Kevin H M Kuo; Nina Kollmar; Heng Wang; Vicky R Breakey; Sujit Sheth; Mukta Sharma; Peter W Forbes; Robert J Klaassen; Rachael F Grace
Journal:  Blood Adv       Date:  2022-03-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.